Literature DB >> 15165916

Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation.

Dwayne S G Conway1, Peter Buggins, Elizabeth Hughes, Gregory Y H Lip.   

Abstract

Atrial fibrillation (AF) is a major cause of morbidity and mortality from stroke due to thromboembolism from the fibrillating left atrium, including its appendage. We hypothesized that indexes of inflammation (as indicated by C-reactive protein and interleukin-6) and indexes of the prothrombotic state in AF that represent platelet activation (soluble P-selectin levels), endothelial damage or dysfunction (von Willebrand factor), coagulation (tissue factor and fibrinogen), and hemorrheology (plasma viscosity and hematocrit) would be related to the presence of thromboembolic predictors on transesophageal echocardiography in patients with long-term AF. To test this hypothesis, we recruited 37 patients with long-term AF who were receiving warfarin therapy with an international normalized ratio of > or =2.0 for > or =3 weeks before transesophageal echocardiography. Twenty-two patients had dense spontaneous echo contrast (SEC) visible in the left atrium or left atrial appendage, 10 had complex atheromatous plaque in the descending aorta, 11 had peak left atrial appendage velocities < or =0.2 m/s, and 3 had thrombus visible in the left atrial appendage. Twenty-eight patients had > or =1 transesophageal echocardiographic (TEE) risk factor for thromboembolism. Plasma levels of C-reactive protein (p = 0.03) and soluble P-selectin (p = 0.04) and hematocrit (p = 0.004) were higher among patients with AF with dense SEC than among those without. No significant associations were found for other TEE risk factors. Hematocrit was the only variable significantly associated with the presence of > or =1 TEE risk factor among patients with AF (p = 0.007) and the only independent associate of dense SEC after multivariate analysis (relative risk 1.4, 95% confidence interval 1.1 to 1.6) per 1% increase in hematocrit (p = 0.003, r(2) = 0.22). Although hematocrit was the only independent associate of dense SEC and > or =1 TEE risk factor, significant associations between dense SEC and the 2 indexes, C-reactive protein and soluble P-selectin, may indicate that mechanisms other than stasis are present with dense SEC. These observations support an "inflammatory hypothesis" in the pathogenesis of SEC that may have implications for thrombogenesis in AF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165916     DOI: 10.1016/j.amjcard.2004.02.032

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  Relationship between spontaneous echo contrast in the thoracic aorta and plasma von Willebrand factor.

Authors:  Takuya Inoue; Makoto Suzuki; Atsushi Namiki; Hironori Hirai; Kaoru Sugi
Journal:  J Med Ultrason (2001)       Date:  2006-12-22       Impact factor: 1.314

Review 2.  Inflammation and the pathogenesis of atrial fibrillation.

Authors:  Yu-Feng Hu; Yi-Jen Chen; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Nat Rev Cardiol       Date:  2015-01-27       Impact factor: 32.419

Review 3.  Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation: A Systematic Review of the Published Data.

Authors:  Karen P Phillips
Journal:  J Atr Fibrillation       Date:  2013-10-31

4.  Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation.

Authors:  Duygu Kocyigit; Kadri Murat Gurses; Muhammed Ulvi Yalcin; Hande Canpinar; Ugur Canpolat; Banu Evranos; Hikmet Yorgun; Necla Ozer; Dicle Guc; Kudret Aytemir
Journal:  J Clin Lab Anal       Date:  2017-03-13       Impact factor: 2.352

5.  The role of high-sensitivity C-reactive protein, interleukin-6 and cystatin C in ischemic stroke complicating atrial fibrillation.

Authors:  Ling You; Peihua Wang; Jiagao Lv; Katherine Cianflone; Daowen Wang; Chunxia Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

6.  Antithrombotic therapy in cardiac embolism.

Authors:  Alvaro Cervera; Angel Chamorro
Journal:  Curr Cardiol Rev       Date:  2010-08

7.  Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.

Authors:  Gregory M Marcus; Mary A Whooley; David V Glidden; Ludmila Pawlikowska; Jonathan G Zaroff; Jeffrey E Olgin
Journal:  Am Heart J       Date:  2007-10-25       Impact factor: 4.749

8.  Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation.

Authors:  Christian Pfluecke; Daniel Tarnowski; Lina Plichta; Katharina Berndt; Paul Schumacher; Stefan Ulbrich; Mathias Forkmann; Marian Christoph; David M Poitz; Carsten Wunderlich; Ruth H Strasser; Karim Ibrahim
Journal:  Clin Res Cardiol       Date:  2015-09-28       Impact factor: 5.460

Review 9.  Cardiac imaging for assessment of left atrial appendage stasis and thrombosis.

Authors:  Jorge Romero; Jie J Cao; Mario J Garcia; Cynthia C Taub
Journal:  Nat Rev Cardiol       Date:  2014-06-10       Impact factor: 32.419

10.  Inflammatory cytokines and atrial fibrillation: current and prospective views.

Authors:  Hadi Ar Hadi; Alawi A Alsheikh-Ali; Wael Al Mahmeed; Jassim M Al Suwaidi
Journal:  J Inflamm Res       Date:  2010-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.